fashion -WSS

fashion

author：focus 2025-10-01 14:59:50 - browse：657

Morgan Griffith -- health policy coverage from STAT — At a Wednesday hearing, Oversight subcommittee Chair Morgan Griffith (R-Va.) mocked Medicare drug price negotiation as “godfather mafia-style negotiation.” Anna Moneymaker/Getty Images

WASHINGTON — Republicans and Democrats fought it out over Medicare drug price negotiation Wednesday at a House hearing, with the former accusing the latter of setting up “mafia-style” theft of property.

Typically, intense hearings like the one before the House Energy and Commerce subcommittee take place when lawmakers are debating legislation, not well after a law passes.

Despite the popularity of Medicare drug price negotiation with voters in both parties, Republicans have attacked the law, known as the Inflation Reduction Act, since Democrats passed it last year. Republicans lawmakers and drugmakers say the drug pricing reforms included in the legislation, which empower Medicare to directly negotiate the prices of some medicines, are tantamount to government price setting and will lead to fewer new drugs. The industry is challenging the program as unconstitutional in multiple courts.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： FDA’s Peter Marks seems inclined to back Sarepta’s gene therapy

explore

WSS

European regulators recommend Amylyx's ALS drug be rejected

Wellcome Trust names Røttingen as its new CEO

Doudna institute plans to 'cure hundreds of diseases' with CRISPR

JPM 2024: FogPharma’s CEO unveils ‘contrarian’ plan in oncology

Health and fitness trackers are measuring the wrong things

Why liver experts renamed NASH to MASH, and NAFLD to MASLD

Wikipedia

fashion

focus

Medical leaders decry Supreme Court decision on affirmative action

What's changing in Medicare's open enrollment this year?

Medicare proposal to cover medical devices draws a mixed reaction

Three issues to watch in global health in 2024

Novavax promises a turnaround & Lilly roils the obesity market

Nick Jonas talks about managing diabetes along with his career

Virginia high school admissions case could be legal follow

Better Therapeutics data on benefit with GLP

Malaria cases in Florida and Texas: Here’s what you need to know

HHS names first

hotspot

FDA’s Peter Marks seems inclined to back Sarepta’s gene therapy

FDA’s Peter Marks seems inclined to back Sarepta’s gene therapy

STAT Readout Newsletter: Today in biotech, life science news

Biotech reporter’s notebook: A sunnier mood at JPM 2024

Eight reasons why you should get an updated Covid vaccine

Medicare to cover more brain scans related to Alzheimer’s drugs

explore

explore

focus

leisure time